The first gene therapy for children with Duchenne muscular dystrophy has been approved by the U.S. Food and Drug Administration. The therapy can be used in 4- and 5-year-olds with the degenerative ...
AS A PARENT, caregiver, or coach, seeing a kid get pumped about fitness and strength can feel kind of amazing. Especially when you consider that only between 21 to 28 percent of kids ages six to 17 ...
(CNN) — The US Food and Drug Administration has approved the first gene therapy to treat a rare and devastating muscle disease but limited the approval to kids ages 4 and 5 based on available evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results